Synthesis of new trypanocidal agents from the hybridisation of metronidazole and eugenol analogues.

Dihydroeugenol Eugenol Guaiacol Molecular hybridisation Triazole Trypanosoma cruzi

Journal

Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 05 12 2023
revised: 12 03 2024
accepted: 13 03 2024
medline: 24 3 2024
pubmed: 24 3 2024
entrez: 23 3 2024
Statut: aheadofprint

Résumé

Nitroimidazole compounds are well-known bioactive substances, and the structural activity relationship has been reported whereby the position of the nitro group within the imidazole ring has a large influence on the activity. This study focuses on synthesising new trypanocidal agents from the hybridisation of metronidazole with different natural phenols (eugenol, dihydroeugenol and guaiacol). Two different coupling methodologies have been explored in order to analyse the influence of the connector on bioactivity: i) classic direct esterification (AD compounds) and ii) "click" chemistry using a triazole connector (AC compounds). The in vitro trypanocidal tests show good results for both AC and AD hybrid compounds against both epimastigote and trypomastigote forms of T. cruzi. In silico studies showed positive data for most of the synthesised compounds and, in general present low toxicological risks. The AC compounds present lower ClogP (lipophilicity) values than those found for the AD series and higher TPSA (topological polar surface area) values, suggesting lower lipophilicity may be related to the presence of the triazole connector. The AD series compounds have higher Drug Score values than the AC series derivatives, suggesting better general properties for a pharmacological action.

Identifiants

pubmed: 38521013
pii: S0045-2068(24)00193-7
doi: 10.1016/j.bioorg.2024.107288
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107288

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mônica Fraccarolli Pelozo (MF)

Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, MG 37130-001, Brazil.

Cleydson Finotti Cordeiro (CF)

Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, MG 37130-001, Brazil.

Letícia Fonseca Inácio (LF)

Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, MG 37130-001, Brazil.

Rayssa de Cassia Alves Lemini (R)

Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, MG 37130-001, Brazil.

Elda Gonçalves Souza E Leite (E)

Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, MG 37130-001, Brazil.

Monique Dias Benedetti (MD)

Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, MG 37130-001, Brazil.

Cristiane Alves Tulha (CA)

Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, MG 37130-001, Brazil.

Rômulo Dias Novaes (RD)

Departamento de Biologia Estrutural, Instituto de Ciências Biomédicas, Universidade Federal de Alfenas, Alfenas 37130-001, Minas Gerais, Brazil.

Ivo Santana Caldas (IS)

Instituto de Ciências Biomédicas, Universidade Federal de Alfenas, MG 37130-001, Brazil.

Diogo Teixeira Carvalho (DT)

Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, MG 37130-001, Brazil.

Stefânia Neiva Lavorato (SN)

Centro de Ciências Biológicas e Saúde, Universidade Federal do Oeste da Bahia, BA 47810-047 Brazil.

Jamie Anthony Hawkes (JA)

Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, MG 37130-001, Brazil.

Lucas Lopardi Franco (LL)

Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, MG 37130-001, Brazil. Electronic address: lucas.franco@unifal-mg.edu.br.

Classifications MeSH